Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Palmoplantar Pustulosis Industry By 2029?

In recent times, there has been significant growth in the market size for palmoplantar pustulosis. From $1.93 billion in 2024, this market is projected to expand to $2.09 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.5%. This growth trajectory during the historic period is due to several factors such as the increasing rate of autoimmune disorders, heightened awareness of uncommon skin diseases, growing healthcare expenditure and the widespread adoption of telemedicine in the Dermatology field.

The market size for palmoplantar pustulosis is projected to experience robust growth in the coming years, escalating to $2.82 billion in 2029, with a compound annual growth rate (CAGR) of 7.7%. The growth within the forecast period can be attributed to factors such as the increased use of biologic therapies, amplified investments in the field of dermatology research, an expanding pipeline of innovative treatments, the increasing need for personalized medicine, and the growing prevalence of chronic skin conditions. Key trends anticipated within the forecast period involve progress in dermatology research, a shift towards biologics and immunomodulators, the incorporation of artificial intelligence in dermatology diagnosis, the creation of advanced topical formulations, and the inclusion of machine learning in dermatological research.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22090&type=smp

Which Industry Forces Are Driving The Palmoplantar Pustulosis Market Forward?

The rise in skin disorders is anticipated to foster the expansion of the palmoplantar pustulosis market in the future. Skin disorders encompass conditions that impact the skin’s design, functionality, or aesthetics. The surge in skin disorders can be attributed to environmental alterations, lifestyle practices, and genetic susceptibility. Environmental elements such as air contamination, severe weather patterns, and exposure to detrimental chemicals can provoke skin irritation and initiate conditions like eczema or acne. Palmoplantar pustulosis is a long-term skin disorder that can particularly affect the skin on hand palms and foot soles, resulting in pustules, inflammation, and flaking. This condition can be controlled through various treatments that enhance skin health and ease discomfort. For example, in 2022, the International Eczema Council, a US-based institution, reported approximately 223 million individuals affected by atopic dermatitis, of which around 43 million were aged between 1 and 4. Hence, the escalating prevalence of skin disorders catalyzes growth in the palmoplantar pustulosis market.

What Is The Segment Breakdown Of The Palmoplantar Pustulosis Market?

The palmoplantar pustulosismarket covered in this report is segmented –

1) By Treatment Type: Topical Treatments; Systemic Treatments; Biologics; Phototherapy

2) By Application: Hospitals; Dermatology Clinics; Homecare Settings

3) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Hospitals

Subsegments:

1) By Topical Treatments: Corticosteroids; Vitamin D Analogues; Calcineurin Inhibitors; Keratolytics

2) By Systemic Treatments: Retinoids; Immunosuppressants; Phosphodiesterase-4 (PDE4) Inhibitors; Corticosteroids

3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin-17 (IL-17) Inhibitors; Interleukin-23 (IL-23) Inhibitors; Interleukin-12/23 (IL-12/23) Inhibitors

4) By Phototherapy: Narrowband UVB Therapy (NB-UVB); Psoralen plus Ultraviolet A (PUVA) Therapy; Excimer Laser Therapy; Targeted Phototherapy

What New Opportunities Are Emerging From Trends In The Palmoplantar Pustulosis Market?

Key companies in the palmoplantar pustulosis market focus on novel therapies such as monoclonal antibodies targeting inflammatory pathways to enhance patient care. Monoclonal antibodies are identical antibodies produced from a single B-cell clone that target specific antigens for therapeutic use. For example, in August 2023, Kyowa Kirin Co., Ltd., a Japanese pharmaceutical company, received partial approval for LUMICEF to treat palmoplantar pustulosis in Japan. LUMICEF blocks IL-17, providing rapid, lasting relief for inflammatory diseases like psoriasis and palmoplantar pustulosis by reducing inflammation and improving patients’ quality of life.

Which Companies Are Contributing Significantly To The Palmoplantar Pustulosis Market Growth?

Major companies operating in the palmoplantar pustulosis market are Pfizer Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis International AG, GlaxoSmithKline PLC (GSK), Amgen Inc., C.H. Boehringer Sohn AG & Co. KG, Bausch Health Companies Inc., Chugai Pharmaceutical Co. Ltd., Janssen Pharmaceuticals Inc., Kyowa Kirin Co. Ltd., Swedish Orphan Biovitrum AB (Sobi), Almirall S.A., MorphoSys AG, MoonLake Immunotherapeutics AG, Aristea Therapeutics Inc., AnaptysBio Inc., Taiho Pharmaceutical Co. Ltd., Kamari Pharma Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/palmoplantar-pustulosis-global-market-report

Which Region Is Leading Innovation In The Palmoplantar Pustulosis Market?

North America was the largest region in the palmoplantar pustulosis market in 2024. The regions covered in the palmoplantar pustulosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=22090&type=smp

Browse Through More Reports Similar to the Global Palmoplantar Pustulosis Market 2025, By The Business Research Company

Natural Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

Organic Skincare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/organic-skincare-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model